distribut product servic
veterinari water test dairi market
leader pet healthcar innov
rang diagnost
revenu
requir disclosur end report
sdma util reiter buy
view current cl king meet event calendar coverag univers
conduct survey veterinarian across differ vet
survey last quarter survey suggest sdma chang
treatment paradigm although survey cant prove lead
adopt new catalyst instrument thesi
expand consum busi laboratori market share suggest
signific long-term oper margin expans although current
valuat exce histor multipl trade slight premium
averag abaxi abaxa hskaa
earn basi reiter buy rate rais price target
thesi expand although current trade newli revis
post-tax reform ep estim okay valuat
believ compani midst three major event continu market
share gain outsid lab new product cycl sdma fecal antigen
test rapid growth outsid companion anim coupl
oper structur room leverag suggest five-year-plu
double-digit earn growth rate think justifi admittedli steep
sdma interest treatment chang interestingli found
veterinarian actual chang way treat cat dog
sdma new develop view previous vet
spoke said sdma help didnt necessarili
treatment plan think paradigm chang could acceler adopt
could lead decent sdma slide util
sdma lead custom twenty-six percent vet said sdma make
like switch keep use eight vet
current use said sdma catalyst make like
switch chemistri suggest us sdma matter
might necessarili lead wave swap-out
swap-out problem found zero vet swap
chemistri instrument last month recal thesi
isnt realli gain market share much grow
categori view low swap-out environ help incumb leader
weve note mani prior note farm strategi
central revenu growth said forward-look basi five
six vet like swap custom
quarterli macro weak futur look strong surprisingli found
weak despit directli follow hurrican disrupt
addit found also weak comp
easier said optim remain high fact vet believ
volum grow come year impli revenu
growth step remov macro data quarter-by-quart
varianc doesnt typic shake number
valuat target price base multipl vs
previous ep estim note neoga
 abaxi averag trade calendar ep estim
adjust model tax reform follow print
model maintain revenu number increas
ep forecast reflect tax reform new ep estim
vs previous respect
model due
tax repatri foreign profit
factset inc note growth rate
survey conduct survey differ vet prior
quarterli survey vet randomli select distribut across
quarter focus sdma launch test catalyst
dx latest thought sedivu fecal antigen test product
well vendor comparison pleas see survey note last
idexx sdma marker sensit earli stage chronic
kidney diseas cat dog theoret mammal compani
initi launch sdma refer lab launch
sdma slide insid lab
intent survey figur vet actual start
chang treatment paradigm sdma
veterinari educ effort check reveal
vet realli know use sdma exampl even interview
vet said dislik sdma client would see lab report
start freak someth wrong pet fact
vet believ pet healthi
page
survey full veterinarian agre statement
practic chang way practic medicin sdma
pretti impress number us impli sdma paramet could
becom routin part veterinari medicin sdma becom
routin part medicin like veterinarian requir marker
figur sdma clinic decis
ultim howev import sdma translat new practic
win product defens ask vet sdma go alter
decis buy retain idexx chemistri instrument slightli
disappoint result averag
neutral vet chemistri decis influenc
surpris big spread particip identifi
custom non- custom
custom vs non- custom fact
former sdma latter hand posit
develop use sdma would think highli addit
although disappoint raw number note eight non-
custom agre sdma catalyst make like buy
chemistri instrument convert custom
would mean increment market share even level prior
page
strongli strongli agre natotalaverageidexx sdma test chang way practic look treat earli chronic kidney applic
figur sdma attitud toward swap-out
competit analysi lab
thesi center abil win account outsid lab
track lab growth vca antech data suggest
win coupl point per year last decad least think
trend hold acceler end decad note
sdma one factor push market share toward addit
concern mar deep emerg practic ownership may hurt
vca antech opportun veterinarian
mars/banfield ownership antech drive custom away even
vca ran antech diagnost ran sever veterinarian mention
chose outsid lab dont want support
competitor ask question back april three month
announc mars/banfield acquisit vca found
vet custom said mar ownership made want use
time around year acquisit found vet said
less like want use antech acquisit addit
said want use antech less current antech
custom think differ veterinarian psycholog
vca ownership mar ownership antech come vca
acquir practic market valu wherea banfield
known open de novo practic though banfield make acquisit well
page
strongli strongli agre natotalaverageth launch sdma catalyst dx chemistri instrument make much like switch keep use applic
figur attitud toward mars/banfield ownership antech
competit environ outsid lab idexx laboratori made
major gain refer lab last year past five survey
shown pick account last month data
suggest trend continu although particular quarter survey
didnt necessarili pick market share shift
dont think trend antech slow anytim soon
fact think control speed shift happen
figur chang primari outsid lab provid last month
page
strongli strongli agre natotalaveragemars/banfield ownership antech make less like want use antech refer applic optionsrespons quarter total quarter averagey antech antech pleas
figur averag chang primari outsid lab provid last month
outsid lab month found six veterinarian said
like like switch refer lab provid last
six quarter found averag veterinarian say practic
like like switch antech essenti
wash said antech user said possibl switch
laboratori provid vs although possibl
vagu categori typic find possibl respond
lock contract
page
answer optionsaveragey antech antech pleas
figur chang primari outsid lab provid month
competit analysi chemistri
advantag separ lab chemistri
refer lab in-hous bundl question around first
bundl insid lab refer lab year abaxi
attempt model avrl offer later sell
page
answer optionsrespons like truli idea even guess intent month like yourpractic switch primari outsid lab provid chang outsid lab monthsov month like possibl switch outsid lab provid next switch come like switch come like come
vca antech agre effect bundl use two
offer give price benefit least perceiv price benefit
current abaxi vca antech inform relationship
opinion flaw parti fight econom deal
said perhap abaxi benefit
refer lab exampl weve heard group practic
dont alway like keep egg one basket opinion
prefer would like bundl thu
idexx cornerston connect advantag mute
fourteen percent vet agre statement prefer use differ
compani outsid lab one use insid lab although
small percentag slightli would expect frankli
dont see advantag separ outsid insid lab vendor
consid resist idexx farm strategi
work increas number product sold exist custom
consequ vet answer strongli disagre read
realli like product bundl vet seem strongli want
expect question would incred high
concentr middl although case pick
neutral think tale question tell import stori
figur differ vendor outsid lab
fulli captur econom insid lab suit want
explor whether hematolog second-most-revenue-gener piec
insid lab equip place near ratio chemistri
survey histor use chemistri proxi entir in-hous suit
page
strongli strongli agre natotalaveragei preferto use differ compani outsid lab one use insid applic
product typic chemistri hematolog blood ga experi
veterinarian compani suggest roughli
tini bit abaxi slightli
interest find significantli larg amount heska
hemtatolog analyz fact found five chemistri custom
use hematolog doubl check particip gave
anomal answer inconsist question overli fast
finish time three minut found noth strang sure
read data point yet
part expect vet want use brand in-hous
equip given synergi one vendor
equip mostli restock one perform manag system
pm part case interestingli vet said
prefer differ vendor piec insid lab equip past
spoke vet classifi rapid test insid lab product weve found
genuin prefer abaxi chemistri user prefer
chemistri user prefer one-off test
page
figur differ insid lab product
contract get look lawyer one distributor rep contact
said abaxi known less rigid contract although still rigid
test use sale pitch lawyer check contract prior
sign compet although distributor
told us think nation strategi doubt tactic deploy
rep regardless thought would interest find
lawyer review contract common vet practic said
lawyer review contract
page
strongli strongli agre natotalaveragei prefer vendor insid lab product chemistri hematolog applic strongli strongli agre natotalaveragei almost alway lawyer review contract purchas servic equip applic
zero swap-out first time ever found zero vet swap
chemistri instrument particular case think benefit
farm activ known client farm although
abaxi announc last quarter hire new sale rep mostli area
farm think low swap-out environ would mostli hurt
view stock valu depend growth market share
figur chang primari chemistri analyz last month
figur competit placement quarter sinc calendar quarter
cl king estim note doesnt provid competit win data count vettest upgrad
futur swap-out forward-look basi found six vet said
like like get new analyz one current scil
custom upgrad scil newest samsung ssnlf nr analyz plan
follow veterinarian month past
note weve enter slow swap-out era follow idexx all-direct
decis doubt slow swap-out environ stop given
two largest player focus farm
page
answer optionsrespons quarter fromabaxi fromabaxi use insid lab pleas primari chemistri analyz last competit competit
note vet particip use slide bar select growth
ask patient volum rather revenu think factor
contribut upward bia data rel pm data
volum averag vet survey said practic volum
grew compar although fair heavili
weight eight vet said volum decreas
disappoint natur disaster-rel event could
push back volum prior quarter wellness-typ visit
saw averag volum
page
answer optionsrespons quarter averageveri like truli idea even guess intent like come like switch come yearwil possibl switch brand next year like switch come year
figur estim chang quarterli patient volum
page
figur roll five-quart averag estim chang quarterli patient
expect volum interest survey found
far biggest disconnect current volum futur volum
exampl found second-lowest three-month growth rate easier
comp well found highest ever forward estim growth
assum price hold steadi reason assumpt given recent
increas inflat fact price beat inflat recent year
would impli industri grow
would far best growth industri ever seen
think optim could bullish anim stock
especi sell capit equip
figur estim direct patient volum month
page
chang patient quarterli volum
figur estim direct patient volum month
figur roll five-quart averag estim direct patient volum
insid lab term instrument market share survey result
line industri estim accord survey
came abaxi came second
overal consist overal estim
abaxi
page
direct volum month
cl king estim scil/samsung ad
figur market share data chemistri analyz brand use exclud dont
outsid lab outsid lab market data similar typic
see market perhap slight antech lean gener
sens market follow vca antech market share
marshfield share
note specif look veterinarian unusu respons
goal vet interview provid gener view specif
veterinarian psycholog use supplement
interview veterinarian three-vet practic locat texa
use scil chemistri
upgrad samsung vet current use scil upgrad scil
samsung analyz summer expir contract ask
henri schein nr own scil analyz scil
samsung analyz cant upgrad sooner said origin bought
analyz financ local bank scil/schein buy
origin agreement weve spoken numer rep three largest
player found lack flexibl scil hardli believ
vet fulli trust accuraci analyz said samsung henri
page
answer optionsrespons use hous pleas analyz brand optionsrespons pleas
schein larg high qualiti compani risk put
veterinarian look three major vendor didnt want work
doesnt work distributor said
nich although dont know mean decis ultim
came samsung analyz abaxi jump
samsung analyz price per month practic get
twenti comprehens panel five panel free
equip get would free said
cheaper abaxi offer
entyce- drug veterinarian alreadi bought aratana petxa
entyc accord effect medic
inappet stock prescrib drug no-brain
interview veterinarian four-and-a-half vet practic locat
massachusett use diagnost
satisfi sedivu vet practic happi
sedivu said practic isnt use practic
includ urin sediment analysi well packag origin
thought would run sedivu turn dont trust result
practic fulli integr practic said like
use instrument get better
gallipr rimadyl practic carri gener drug
typic prescrib rimadyl pain practic vet first
choic pharmaceut carri in-hous ask
gallipr said doesnt normal prescrib price said
long-term use pain medic would requir frequent visit even
though gallipr shown better safeti profil said practic
requir regular bloodwork patient prescrib pain medic
includ gallipr even better safeti profil although didnt
directli state answer gave us impress practic look
regular bloodwork prescrib pain med mean continu
see patient regular interv
risk achiev price target
risk includ acquisit zoeti abaxi currenc
geopolit environ relianc distributor regul multipl sole
supplier vet industri macro situat price concess competit
page
